1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    A woman wearing yellow smiles and drinks coffee while on laptop.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    Guess which ASX 200 stock defied today's downturn to gain 4.8%.

    Read more »

    Five people in an office high five each other.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    One ASX 200 tech share outperformed all others on Friday.

    Read more »

    happy business people celebrate, share rise, record price, increase
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    Do you own any of today's top performing ASX 200 favourites?

    Read more »

    Top ten gold trophy.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    One ASX 200 healthcare stock outperformed all others today.

    Read more »

    high share price
    Share Gainers

    Why Arafura Rare Earths, Imugene, Pilbara Minerals, and Worley are charging higher

    | James Mickleboro

    These ASX shares are overcoming the market weakness and having a good session on Tuesday.

    Read more »

    Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
    Healthcare Shares

    Up 6%, guess which ASX 200 stock is the best performing so far today

    | Bronwyn Allen

    ASX 200 healthcare share Imugene is leading the market today.

    Read more »

    Medical technicians wearing white medical coats conduct a test in a laboratory.
    Healthcare Shares

    What's with the Imugene share price today?

    | Bronwyn Allen

    Investors appear to be pleased with the immuno‐oncology biotech's progress.

    Read more »

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    Healthcare Shares

    Why has ASX 200 healthcare stock Imugene leapt 15% in a month?

    | Monica O'Shea

    Let's check what's been going on with this biotechnology company lately.

    Read more »

    A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    Guess which lithium stock outperformed all other ASX 200 shares today.

    Read more »

    A woman with a broad smile on her face holds up ten fingers.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    An ASX travel share notched the biggest gain on Thursday.

    Read more »

    Ordinary Australians waiting at the bus stop using their phones to trade ASX 200 shares today
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    One ASX 200 health care stock outperformed all others on Thursday.

    Read more »

    share price high, all time record, record share price, highest, price rise, increase, up,
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    The ASX 200 put on a volatile performance on Wednesday.

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note